Moderna
MRNA
$26.67
Share price
8.24%
Change (1 day)
-76.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Total assets
Total assets on the balance sheet as of December 2024 : $14.14 Billion USD
According to Moderna 's latest financial reports the company's total assets are $14.14 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Moderna - Total assets on balance sheet (from 2017 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $14.14 B | -23.25% |
| 2023-12-31 | $18.42 B | -28.74% |
| 2022-12-31 | $25.85 B | 4.82% |
| 2021-12-31 | $24.66 B | 236.23% |
| 2020-12-31 | $7.33 B | 361.61% |
| 2019-12-31 | $1.58 B | -19% |
| 2018-12-31 | $1.96 B | 80.93% |
| 2017-12-31 | $1.08 B | -23.47% |
| 2016-12-31 | $1.41 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | $84.18 M | -99.40% | 🇺🇸 USA |
 | $117.10 B | 728.07% | 🇺🇸 USA |
 | $7.42 M | -99.95% | 🇺🇸 USA |
 | $4.23 B | -70.02% | 🇺🇸 USA |
 | $102.24 B | 623.00% | 🇨🇭 Switzerland |
 | $1.01 B | -92.83% | 🇺🇸 USA |
 | $180.10 B | 1,173.54% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |